NanoViricides Inc. (NNVC)

[Puffer]

you are assuming an efficient market, often not the case with penny stocks where retail investors control the float.

There are 3 key factors that are not priced into the stock here --

1. The "drug" (flucide) does not alter cell function thus rendering the odds of toxicity much lower than your typical drug.

2. Human clinical trials likely less than 12 months away.

3. Due to the self-limiting nature of the flu, those clinical trials, all phases, can be completed in total in a few months, unlike your typical cancer drug, for example, that can take more like 7 yrs to complete trials.

This is all complicated somewhat by the situation with Seaside which continues to dump stock into the market for short term profit, unrelated to the fundamentals of the company.... another reason why it is not efficiently priced here.